Cape Verde vs Guinea-Bissau: Antiretroviral therapy coverage for PMTCT
Cape Verde
80.0%
in 2024
Guinea-Bissau
79.0%
in 2024
Cape Verde rank
41st
Guinea-Bissau rank
43rd
Antiretroviral therapy coverage for PMTCT over time
- Cape Verde
- Guinea-Bissau
How they compare
Cape Verde currently reports 80.0% against 79.0% in Guinea-Bissau, a difference of 1.0%.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was Guinea-Bissau ahead.
Cape Verde ranks 41st and Guinea-Bissau ranks 43rd of 84 countries.
Across the 3 decades both report, Cape Verde averaged higher in 2 and Guinea-Bissau in 1.
Head to head by decade
| Decade | Cape Verde | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 3.1% | 3.1% | Guinea-Bissau |
| 2010s | 100.0% | 64.7% | 35.3% | Cape Verde |
| 2020s | 88.8% | 68.6% | 20.2% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Cape Verde or Guinea-Bissau?
- Cape Verde, at 80.0% against 79.0% in Guinea-Bissau as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Cape Verde and Guinea-Bissau?
- 1.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Guinea-Bissau?
- 25 years are reported by both, from 2000 to 2024.
- How do Cape Verde and Guinea-Bissau rank globally for antiretroviral therapy coverage for pmtct?
- Cape Verde ranks 41st and Guinea-Bissau ranks 43rd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).